Push Health vs Willow
Willow costs $651 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Willow
Best for: seeing what it charges before you answer any medical questions
Visit Willow →If you are choosing between Push Health and Willow, the first difference is cost: Willow is $651 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Willow leads our six-part score, 6.6 to 5.6.
Push Health vs Willow price
Willow is the cheaper way in: $299 a month against $950 a month at Push Health. That is $651 less each month (69% lower), or about $7,812 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Willow ($299 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only Willow lists tirzepatide.
On format, Push Health prices brand-name pens, while Willow prices compounded injections.
If you want the FDA-approved brand rather than a compounded version, Push Health is the only one of the two with a brand-name price.
Where each one treats patients
Neither Push Health nor Willow publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Push Health
Ozempic / brand
Willow
What each price covers
Willow's price also covers the clinician visit, the medication itself and shipping, which Push Health does not claim.
Push Health does not say what its price includes.
Willow is silent on lab work and coaching.
That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.
Push Health
Inclusions not disclosed.
Willow
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Where each one scores higher
Overall, Willow scores 6.6 and Push Health 5.6 out of 10.
Push Health is stronger on value (5.3 vs 3.0).
Willow is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0), trust & safety (6.5 vs 4.0) and support (7.0 vs 5.0).
Accessibility is within half a point.
Push Health
5.6/10
Willow
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Push Health nor Willow has an FDA warning letter on record with us.
Features & Coverage
| Feature | Push Health | Willow |
|---|---|---|
| Starting Price | $950/mo | ✓$299/mo |
| Features | ✓5 features | 3 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | — | ✓ Yes |
| Brand Name | ✓ Yes | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →About Willow
Tablets and injections are both on offer at Willow, a telehealth seller of compounded GLP-1 medications.
Read our full Willow review →Pros & Cons
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Willow
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to Willow
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Willow wins this one, 6.6 to 5.6, above all for seeing what it charges before you answer any medical questions. It also costs $651 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Choose Willow if…
You want seeing what it charges before you answer any medical questions and an opening price near $299 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Breeze Meds
Knowing which pharmacy fills the vial: it names Belmar Pharmacy
From $199/mo
Get started →HealthRX
Compounded semaglutide at $133/month
From $133/mo
Get started →RNK Health
An oral route if you will not self-inject
From $197/mo
Get started →Push Health vs Willow: FAQ
Close alternatives to Push Health and Willow
- Push Health vs JumpstartMD
- Push Health vs Marek Health
- Push Health vs Cost Plus Drugs
- Push Health vs Medi-Weightloss
- Willow vs Remedy Meds
- Willow vs Apex MD
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.